Skip to content

MapLight Therapeutics, Inc. MPLT Balance Sheet Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$55.71M$46.73M+22.2%$64.15M
$254.41M$258.37M+266%$163.02M
$327.23M$324.67M+183%$245.31M
$968K$1.1M-9.3%$859K
$418.79M$479.51M+250%$257.22M
$3.19M+404%$3.29M+72.0%$2.45M-$1.05M
$14.28M$16.23M+1.9%$18.56M
$18.95M$21.14M-2.7%$23.71M
$5K$5K$0
-$421.19M-$360.52M-80.8%-$280.97M
$399.83M+285%$458.37M+337%-$274.18M-59.1%-$245.06M-58.8%-$215.83M-58.7%
$418.79M$479.51M+250%$257.22M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are MapLight Therapeutics, Inc. 's total assets?
MapLight Therapeutics, Inc. (MPLT) holds $418.8M in total assets.
How much debt does MapLight Therapeutics, Inc. have?
MapLight Therapeutics, Inc. carries $5.6M in total debt against $399.8M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does MapLight Therapeutics, Inc. have?
MapLight Therapeutics, Inc. holds $55.7M in cash and equivalents.
Can MapLight Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 22.91 — current assets exceed current liabilities.
Where does MapLight Therapeutics, Inc. 's balance sheet data come from?
Every line is extracted from MapLight Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.